Aparna Jaswal

  • Citations Per Year
Learn More
BACKGROUND Several past clinical studies have demonstrated that frequent and unnecessary right ventricular pacing in patients with sick sinus syndrome and compromised atrio-ventricular conduction (AVC) produces long-term adverse effects. The safety and efficacy of two pacemaker algorithms, Ventricular Intrinsic Preference™ (VIP) and Ventricular AutoCapture(More)
St. Jude Medical (SJM) has recently announced a global medical device advisory that was also communicated by US FDA in a letter dated 11th October 2016 [1]. The advisory related to the risk of premature battery depletion in some of the implantable cardioverter-defibrillator (ICD) and Cardiac Resynchronization Therapy e Defibrillator (CRT-D) devices(More)
Cardiac Resynchronisation Therapy (CRT) has been used extensively over the last years in the therapeutic management of the patients with end stage heart failure based on the data of large randomized trials on CRT. CRT improves symptoms, exercise capacity, quality of life and echocardiographic indices of severe systolic heart failure besides reduction in(More)
BACKGROUND The PANARrhythMia and Heart Failure Registry (PANARM HF) characterized demographic, clinical and interventional therapy indication profiles of cardiac arrhythmia (CA) and heart failure (HF) patients in India. METHODS Consulting Physicians (CP) who medically manage CA and HF patients enrolled patients with one or more of the following: syncope,(More)
  • 1